High-risk atherosclerotic cardiovascular disease in a real-world employed japanese population: Prevalence, cardiovascular event rates, and costs

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 12, 2015, Pages 1287-1304

  Davis, Keith L ^a   Meyers, Juliana ^a   Zhao, Zhenxiang ^b   McCollam, Patrick L ^b   Murakami, Masahiro ^c  

^a RTI HEALTH SOLUTIONS   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Medicines Development Unit Japan   (Japan)

Author keywords

Cardiovascular events; Costs; High risk atherosclerotic cardiovascular disease; Incidence; Japan

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY ATHEROSCLEROSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; JAPANESE (PEOPLE); LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDY; UNSTABLE ANGINA PECTORIS; ANGINA, UNSTABLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COMPLICATION; ECONOMICS; EMPLOYMENT; HEALTH CARE COST; HOSPITALIZATION; JAPAN; PATIENT SELECTION;

ANGINA, UNSTABLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; JAPAN; MALE; MIDDLE AGED; PATIENT SELECTION; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84948977686     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.28852     Document Type: Article

References (36)

1. Japan Health and Welfare Statistics Association. Kokumin- eisei no Douko (Trends for National Hygiene2008. J Health and Welfare Stat 2008 (in Japanese.
2. Hyre AD, Muntner P, Menke A, Raggi P, He J. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol. 2007; 17(7: 548-55.
3. de Rojas FD, De Frutos T, Ponte A, Chacón JM, Vitale GC. Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study. Prev Cardiol 2009; 12: 65-71.
4. Müller-Nordhorn J, Englert H, Wegscheider K, Berger H, Sonntag F, Völler H, Meyer-Sabellek W, Reinhold T, Windler E, Katus HA, Willich SN.. Productivity loss as a major component of disease-related costs in patients with hypercholesterolemia in Germany. Clin Res Cardiol 2008; 97: 152-9.
5. Zhao Z, Zhu Y, Fang Y, McCollam PL. Demographic and clinical characteristics, and treatment of cardiovascular risk factors in working age patients with high-risk vascular disease: Findings from a mulit-employer U.S. claims database. ISPOR 18th Annual International Meeting; May 22, 2013: Abstract PCV129.
6. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994; 1: 333-9.
7. Lahoz C, Mostaza JM. Atherosclerosis as a systemic disease. Rev Esp Cardiol (Engl Ed. 2007; 60: 184-95.
8. Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and lifethreatening consequences. Eur Heart J 2004; 25: 1197-207.
9. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PW. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180-189.
10. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr., Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197-206.
11. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-504.
12. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J; Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL Study Group.. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 2005; 294: 2437-45.
13. Adams HP Jr.. Secondary prevention of atherothrombotic events after ischemic stroke. Mayo Clin Proc 2009; 84(1: 43–51.
14. Bhatt DL. Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events. J Invasive Cardiol 2003; 15(suppl B: 3B-10B.
15. Mahoney EM, Wang K, Cohen DJ, Hirsch AT, Alberts MJ, Eagle K, Mosse F, Jackson JD, Steg PG, Bhatt DL; REACH Registry Investigators.. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes 2008; 1: 38–45.
16. World Health Organization. Global Health Observatory Data Repository, Life Expectancy by Country. Available at: http: //apps.who.int/gho/data/view.main.680?lang=en. Accessed October 29, 2013.
17. Ueshima H. Explanation for the Japanese paradox: pre vention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb 2007; 14(6: 278-86.
18. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, Yoshimasa Y, Okayama A. Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the Suita study. Atherosclerosis 2010; 209(1: 290-4.
19. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society.. Executive summary of the Japan Atherosclerosis Society (JAS guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version. J Atheroscler Thromb 2013; 20(6: 517-23.
20. Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, Shimokawa H; MIYAGI-AMI Study Investigators. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circ J 2010; 74(1: 93-100.
21. Kitamura A, Noda H, Nakamura M, Kiyama M, Okada T, Imano H, Ohira T, Sato S, Yamagishi K, Iso H.. Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS. J Atheroscler Thromb 2011; 18(6: 454-63.
22. Dixon JR Jr.. The International Conference on Harmonization Good Clinical Practice guideline. Qual Assur 1998; 6(2: 65-74.
23. Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008; 61(12: 1234-40.
24. Yoshida M, Kita Y, Nakamura Y, Nozaki A, Okayama A, Sugihara H, Kasamatsu T, Hirose K, Kinoshita M, Ueshima H. Incidence of acute myocardial infarction in Takashima, Shiga, Japan. Circ J 2005; 69(4: 404-8.
25. Rumana N, Kita Y, Turin TC, Murakami Y, Sugihara H, Morita Y, Tomioka N, Okayama A, Nakamura Y, Abbott RD, Ueshima H. Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI Registry, 1990-2001. Am J Epidemiol 2008; 167(11: 1358-64.
26. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, Nakamura H, Okubo K, Iida M. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 2349-54.
27. Ishikawa S, Kayaba K, Gotoh T, Nago N, Nakamura Y, Tsutsumi A, Kajii E. Incidence of total stroke, stroke subtypes, and myocardial infarction in the Japanese population: the JMS Cohort Study. J Epidemiol 2008; 18(4: 144-50.
28. Ohnishi H, Sawayama Y, Furusyo N, Maeda S, Tokunaga S, Hayashi J. Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS. J Atheroscler Thromb. 2010; 17(7: 751-8.
29. Fujiwara T, Saitoh S, Takagi S, Ohnishi H, Ohata J, Takeuchi H, Isobe T, Chiba Y, Katoh N, Akasaka H, Shimamoto K.. Prevalence of asymptomatic arteriosclerosis obliterans and its relationship with risk factors in inhabitants of rural communities in Japan: Tanno-Sobetsu study. Atherosclerosis, 2004; 177: 83-88.
30. Hozawa A, Ohmori K, Kuriyama S, Shimazu T, Niu K, Watando A, Ebihara S, Matsui T, Ichiki M, Nagatomi R, Sasaki H, Tsuji I.. C-reactive protein and peripheral artery disease among Japanese elderly: the Tsurugaya Project. Hypertens Res, 2004; 27: 955-961.
31. Cui R, Kitamura A, Yamagishi K, Tanigawa T, Imano H, Ohira T, Sato S, Shimamoto T, Iso H. Ankle-arm blood pressure index as a correlate of preclinical carotid atherosclerosis in elderly Japanese men. Atherosclerosis, 2006; 184: 420-424.
32. Uchiyama S, Goto S, Matsumoto M, Nagai R, Origasa H, Yamazaki T, Shigematsu H, Shimada K, Yamada N, Bhatt DL, Steg PG, Ikeda Y; REduction of Atherothrombosis for Continued Health Registry Investigators. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry. J Neurol Sci 2009; 287(1-2: 45-51.
33. Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, Röther J, Salette G, Goto S, Smith SC Jr., Liau CS, Wilson PW, Steg PG; REduction of Atherothrombosis for Continued Health Registry Investigators. Three-year follow- up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J 2009; 30(19: 2318-26.
34. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63(25 Pt B: 2889-934.
35. World Health Organization National Health Account Database.http://data.worldbank.org/indicator/SH.XPD. PCAP. Accessed January 2014.
36. Japan Statistics Bureau. Ministry of Internal Affairs. Employed Persons by Age, Industry (Table 11. Available at: http: //www.e-stat.go.jp/SG1/estat/ListE. do?lid=000001105914.Accessed November 2013.